PB 38 of 2016
National Health (Originator Brand) Amendment Determination 2016 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.
Dated 29 April 2016
_____________________________________
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
(1) This Determination is the National Health (Originator Brand) Amendment Determination 2016 (No. 3).
(2) This Determination may also be cited as PB 38 of 2016.
This Determination commences on 1 May 2016.
3 Amendments to PB 100 of 2015
Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).
Schedule 1 Amendments
(section 3)
[1] Schedule 1 (after table item 78)
Insert:
78A | Esomeprazole and Clarithromycin and Amoxycillin | Nexium Hp7 |
|
|